These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2010-018866-21 Intensified program including Bendamustine followed by PBSC mobilization and high dose therapy and autograft for patients with relapsed or resistant CD 20+ Follicular Non Hodgkin Lymphoma: a multicen... not-yet-due
Ongoing 2014-001603-42 “Arrest Imatinib or Dasatinib in CML patients with Deep Molecular Responses” (AID MORE) "Interruzione di Imatinib o Dasatinib in pazienti con LMC con risposta molecolare profonda" (AID MORE) not-yet-due